← Eichor
Study identifier: NCT07209488 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Acquired Dyslexia Modeling and Treatment

Condition: Stroke · Dyslexia, Acquired  ·  Sponsor: Rutgers, The State University of New Jersey

PhaseNA
Planned participants12
Who can joinAll sexes, 18 Years to 85 Years
Healthy volunteersNo

About this study

This study is a low-risk, early phase 1, multicenter trial to test the use of a computational (neural network) cognitive model of reading to simulate acquired dyslexia and its treatment. The aim is to determine whether there is an advantage to receiving the treatment the model predicts to be advantageous compared to the alternative treatment. All participants will receive two full rounds of treatment. A round of treatment will consist of either phonomotor treatment (PMT) or semantic feature analysis (SFA) for 60 hours, distributed over 5 days a week for 2 hours a day.

This description comes directly from the study's public registry record.

Talk to the study team

William W Graves, PhD  ·  973-353-3947  ·  william.graves@rutgers.edu

Olga Boukrina, PhD  ·  973-324-3587  ·  OBoukrina@KesslerFoundation.org

Always discuss trial participation with your own doctor first.

Locations (3)

Florida State UniversityTallahassee, Florida, United StatesRecruiting
Johns Hopkins University School of MedicineBaltimore, Maryland, United StatesRecruiting
Kessler FoundationWest Orange, New Jersey, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07209488